Clinical Trial

Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent Tumors

Study acronym: HETERERO
Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated December 26, 2023 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.
Summary
This study investiagates deep-regional or superficial hyperthermia to enhance radiotherapy or chemoradiation in patients that suffer recurrent disease after previous radiotherapy.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2021-05-12.
Status change: Recruiting → Not Yet Recruiting 2023-12-19
Trial Details
NCT Number NCT04889742
Lead Sponsor Charite University, Berlin, Germany
Conditions Recurrent Cancer, Prostate Cancer, Cervical Cancer, Anal Cancer, Sarcoma, Rectal Cancer, Neuroendocrine Tumors, Esophageal Cancer +2 more
Enrollment 110 participants
Start Date 2024-05-10
Primary Completion 2026-01 (estimated)
Study Completion 2028-01 (estimated)
Updated on ClinicalTrials.gov 2023-12-26